National HealthCare Corporation NHC R2K

Healthcare · Medical Care Facilities · United States

https://www.nhccare.com

National HealthCare Corporation engages in the operation of services to skilled nursing facilities, assisted and independent living facilities, homecare and hospice agencies, and health hospitals. It operates through two segments: Inpatient and Homecare and Hospice Services. The company's skilled nursing facilities offer licensed therapy services, nutrition services, social services, activities, and housekeeping and laundry services, as well as medical services prescribed by physicians; and rehabilitative services, such as physical, speech, respiratory, and occupational therapy for patients recovering from strokes, heart attacks, orthopedic conditions, neurological illnesses, or other illnesses, injuries, or disabilities. It provides medical specialty units comprise memory care units and sub-acute nursing units that provide specialized care and programs for persons with Alzheimer's or related disorders; and assisted living facilities offer personal care services and assistance with general activities of daily living, such as dressing, bathing, meal preparation, and medication management. Its independent living facilities offers specially designed residential units for the active and ambulatory elderly and provide various ancillary services for residents, including restaurants, activity rooms and social areas; and behavioral health services to both adults and geriatric patients with psychiatric, emotional, and addictive disorders. In addition, the company homecare agencies assist those who wish to stay at home or in assisted living residences but still require some degree of medical care or assistance with daily activities; hospice agencies that provides hospice and palliative care; and operates pharmacies, as well as managed care insurance solutions. Further, the company offers management, accounting, and financial services; and leases its properties to third party operators. The company was founded in 1971 and is based in Murfreesboro, Tennessee.

Market & Price

Market Cap

$2.88B

Current Price

$184.42

High / Low (52W)

$199.51 / $93.18

Beta

0.65

Valuation

Stock P/E

23.43

Industry PE

23.65

Forward P/E

428.88

PEG Ratio

0.82

Book Value

$69.90

Price to Book

2.64

P/S

1.89

EV/EBITDA

15.21

Dividend Yield

1.40%

Profitability & Returns

ROCE

13.26%

ROE

12.01%

ROA

5.28%

Profit Margin

8.10%

Op Margin

8.45%

EPS (Latest Qtr)

$2.27

EPS (TTM)

$7.87

Balance Sheet & Liquidity

Debt/Equity

3.58

Quick Ratio

1.58

Current Ratio

1.86

Debt

$39.31M

Total Assets

$1.53B

Current Assets

$461.82M

Working Capital

$208.19M

Ownership

Promoter Holding

18.93%

Chg in Prom Hold

FII / Inst Holding

67.62%

Chg in FII Hold

-0.00%

Financial Snapshot

Enterprise Value

$2.67B

Total Revenue (TTM)

$1.53B

EBITDA

$175.39M

Free Cash Flow

$118.57M

Operating Cash Flow

$208.36M

Shares Outstanding

15.62M

Gross Margin

39.18%

Payout Ratio

32.53%

Growth (CAGR)

Revenue 5Y

12.21%

Profit 5Y

74.87%

Revenue (YoY)

2.20%

Earnings (YoY)

9.70%

PROS

Compounding revenue at 12.2% over 5 years.
Profit CAGR of 74.9% over 5 years.
Generates positive free cash flow.
In a confirmed uptrend (50-DMA above 200-DMA).

CONS

No notable concerns flagged.

* The pros and cons are auto-generated from financial metrics.

Price Chart

Robinhood TradingView StockAnalysis

Fundamental Growth

Period: Metric:

Figures from the latest reported periods. CAGR is computed across the displayed window (quarterly CAGR is annualised assuming 4 quarters per year).

Peer comparison

Peer companies in the same sector (Healthcare).

#	Name	CMP $	P/E	Mkt Cap	Div Yld %	ROCE %	ROE %	Rev CAGR 5Y %	Profit CAGR 5Y %
1	NHC National HealthCare Corporation R2K	184.42	23.43	$2.88B	1.40%	13.26%	12.01%	12.21%	74.87%
2	LLY Eli Lilly and Company SPX	1,105.00	39.21	$985.37B	0.63%	38.44%	107.46%	31.69%	48.96%
3	JNJ Johnson & Johnson SPX	225.33	26.11	$542.42B	2.38%	23.13%	26.42%	5.60%	14.32%
4	UNH UnitedHealth Group Incorporated SPX	380.31	28.66	$345.38B	2.32%	9.60%	12.18%	11.35%	-15.69%
5	MRK Merck & Co., Inc. SPX	118.72	33.44	$293.22B	2.86%	20.66%	18.94%	3.12%	7.93%
6	TMO Thermo Fisher Scientific Inc. SPX	492.51	27.11	$183.03B	0.38%	9.17%	13.52%	-0.27%	-1.19%
7	AMGN Amgen Inc. NDXSPX	336.79	23.42	$181.77B	2.99%	18.02%	101.32%	11.77%	5.58%
8	GILD Gilead Sciences, Inc. NDXSPX	134.43	18.29	$166.90B	2.44%	22.92%	43.36%	2.57%	22.83%
9	ISRG Intuitive Surgical, Inc. NDXSPXAI	424.64	51.53	$150.39B	-	15.96%	17.23%	17.39%	29.26%

Quarterly Results

Figures in USD.

Metric	Jun 2015	Sep 2015	Dec 2015	Mar 2016	Jun 2016	Sep 2016	Dec 2016	Mar 2017	Jun 2017	Sep 2017	Dec 2017	Mar 2018	Jun 2018	Sep 2018	Dec 2018	Mar 2019	Jun 2019	Sep 2019	Dec 2019	Mar 2020	Jun 2020	Sep 2020	Mar 2021	Jun 2021	Sep 2021	Mar 2022	Jun 2022	Sep 2022	Mar 2023	Jun 2023	Sep 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Revenue	-	-	-	-	-	-	-	238.54M	238.69M	241.20M	246.31M	242.96M	242.14M	246.33M	248.92M	248.28M	247.15M	247.07M	253.88M	256.12M	261.64M	250.63M	250.97M	263.16M	276.74M	278.98M	271.36M	270.84M	269.56M	282.58M	288.49M	297.18M	300.66M	340.20M	-	373.70M	374.91M	382.66M	386.51M	381.82M
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	228.13M	226.53M	233.18M	233.24M	235.07M
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	145.57M	148.38M	149.49M	153.27M	146.75M
Operating Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	114.80M	114.29M	119.11M	120.16M	114.49M
Operating Income	15.71M	13.76M	20.22M	17.62M	14.64M	10.59M	17.69M	15.86M	12.14M	9.79M	16.32M	15.88M	12.16M	10.83M	17.19M	15.78M	10.19M	6.57M	16.50M	15.80M	12.55M	7.02M	15.22M	13.79M	12.76M	14.22M	4.55M	4.08M	10.01M	13.98M	13.03M	15.68M	22.52M	22.79M	-	30.77M	34.09M	30.38M	33.12M	32.25M
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	56.81M	45.18M	67.02M	44.72M	56.70M
Interest Expense	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2.11M	1.99M	1.46M	816.00K	269.00K
Pretax Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	43.72M	32.17M	54.41M	32.13M	44.81M
Tax Provision	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	11.43M	8.05M	13.40M	6.94M	8.71M
Net Income	12.36M	12.57M	14.98M	13.70M	11.87M	11.11M	13.86M	12.73M	10.65M	11.35M	-	-2.79M	22.46M	21.14M	-	21.27M	13.71M	19.46M	-	-26.85M	28.32M	12.85M	21.27M	104.88M	-3.35M	15.32M	3.20M	-2.43M	11.72M	16.28M	10.39M	26.21M	26.84M	42.79M	-	32.20M	23.72M	39.24M	24.85M	35.86M
Diluted EPS	0.71	0.72	0.99	0.91	0.78	0.73	0.91	0.84	0.70	0.75	1.41	-0.18	1.47	1.39	1.19	1.39	0.89	1.27	0.89	-1.76	1.84	0.84	1.38	6.80	-0.22	0.99	0.21	-0.16	0.76	1.06	0.68	1.69	1.73	2.73	-	2.07	1.52	2.50	1.58	2.27

Profit & Loss (Annual)

Figures in USD.

Metric	Dec 2010	Dec 2011	Dec 2012	Dec 2013	Dec 2014	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Revenue	-	-	-	-	-	-	923.58M	963.89M	980.35M	996.38M	1.03B	-	1.07B	1.14B	1.30B	1.52B
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	686.17M	712.34M	810.93M	921.08M
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	388.11M	429.20M	487.01M	596.70M
Operating Expenses	-	-	-	-	-	-	-	-	-	-	-	-	359.38M	371.74M	397.11M	468.35M
Operating Income	57.63M	78.85M	68.24M	72.08M	68.01M	67.13M	60.54M	54.11M	56.08M	49.04M	48.16M	-	28.73M	57.46M	89.89M	128.35M
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	68.28M	131.10M	182.53M	213.72M
Interest Expense	-	-	-	-	-	-	-	-	-	-	-	-	563.00K	324.00K	4.13M	6.37M
Pretax Income	-	-	-	-	-	-	-	-	-	-	-	-	27.23M	88.74M	136.41M	162.43M
Tax Provision	-	-	-	-	-	-	-	-	-	-	-	-	7.25M	23.45M	34.32M	39.83M
Net Income	52.70M	64.99M	59.30M	64.61M	53.37M	53.14M	50.54M	56.20M	58.96M	68.21M	41.87M	-	22.45M	66.80M	101.93M	120.02M
Diluted EPS	3.22	3.96	3.57	3.87	3.14	3.20	3.32	3.69	3.87	4.44	2.72	-	1.45	4.34	6.53	7.67

Compounded Sales Growth

5 Years:	12.21%
1 Year:	2.20%

Compounded Profit Growth

5 Years:	74.87%
1 Year:	9.70%

Stock Price Performance

1 Year:	+80.62%
6 Months:	+34.84%
3 Months:	+13.24%
1 Month:	+5.34%

Balance Sheet (Annual)

Figures in USD.

Metric	Dec 2009	Dec 2010	Dec 2011	Dec 2012	Dec 2013	Dec 2014	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Sep 2024	Dec 2024	Dec 2025
Total Assets	-	-	870.42M	924.70M	984.36M	1.07B	1.05B	1.09B	1.10B	1.08B	1.29B	1.36B	-	1.28B	1.31B	-	1.52B	1.53B
Current Assets	-	-	-	-	-	-	-	-	-	-	-	-	-	353.93M	406.24M	-	424.41M	461.82M
Cash & Equivalents	39.02M	28.48M	61.01M	66.70M	81.70M	69.77M	38.21M	26.34M	59.12M	43.25M	50.33M	147.09M	-	58.67M	107.08M	-	76.12M	92.83M
Inventory	-	-	-	-	-	-	-	-	-	-	-	-	-	7.09M	7.39M	-	9.04M	7.79M
Receivables	-	-	-	-	-	-	-	-	-	-	-	-	-	99.99M	108.55M	-	135.32M	139.00M
Total Liabilities	-	-	-	-	-	-	-	417.84M	393.09M	346.49M	507.58M	563.87M	-	397.94M	400.32M	-	541.27M	451.90M
Current Liabilities	-	-	220.66M	228.76M	167.76M	183.56M	150.66M	150.93M	155.06M	157.92M	194.76M	281.23M	-	197.89M	214.48M	-	234.80M	253.63M
Long Term Debt	-	-	10.00M	10.00M	10.00M	10.00M	120.00M	120.00M	100.00M	55.00M	0	-	-	-	-	129.50M	129.50M	32.50M
Total Debt	-	-	-	-	-	-	-	-	-	-	-	-	-	125.94M	93.39M	-	214.77M	87.07M
Total Equity	525.78M	555.36M	606.87M	656.15M	688.11M	734.15M	631.00M	669.61M	702.74M	733.28M	778.59M	795.18M	-	874.28M	908.75M	-	980.16M	1.07B
Shares Outstanding	-	-	-	-	-	-	-	-	-	-	-	-	-	15.36M	15.35M	-	15.45M	15.54M

Cash Flows (Annual)

Figures in USD.

Metric	Dec 2010	Dec 2011	Dec 2012	Dec 2013	Dec 2014	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Operating Cash Flow	63.36M	82.36M	64.37M	102.35M	75.69M	83.36M	90.88M	94.47M	98.44M	100.10M	203.26M	-	8.74M	111.22M	107.30M	185.08M
Investing Cash Flow	-46.35M	-31.75M	-31.23M	-56.30M	-57.51M	-72.78M	-81.48M	-9.56M	-33.66M	-14.27M	-63.88M	-	-5.98M	-17.57M	-236.69M	-33.86M
Financing Cash Flow	-27.55M	-18.08M	-27.45M	-31.04M	-30.12M	-41.67M	-27.13M	-49.07M	-77.27M	-79.75M	-41.89M	-	-47.64M	-42.55M	100.34M	-135.96M
Capital Expenditure	-32.29M	-23.37M	-22.00M	-43.44M	-53.30M	-58.42M	-62.60M	-32.35M	-29.77M	-26.40M	-21.87M	-	-30.20M	-27.90M	-27.60M	-36.45M
Free Cash Flow	31.07M	58.99M	42.37M	58.91M	22.40M	24.94M	28.28M	62.12M	68.66M	73.70M	181.39M	-	-21.46M	83.31M	79.70M	148.63M
Net Change in Cash	-	-	-	-	-	-	-	-	-	-	-	-	-44.88M	51.10M	-29.05M	15.27M
Share Buybacks	5.94M	-	-	4.70M	7.00M	-	8.20M	0	867.00K	872.00K	53.00K	836.00K	9.90M	2.48M	13.50M	14.73M

Ratios (Annual)

Figures in %.

Metric	Dec 2010	Dec 2011	Dec 2012	Dec 2013	Dec 2014	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Gross Margin %	-	-	-	-	-	-	-	-	-	-	-	-	36.1%	37.6%	37.5%	39.3%
Operating Margin %	-	-	-	-	-	-	6.6%	5.6%	5.7%	4.9%	4.7%	-	2.7%	5.0%	6.9%	8.5%
Net Margin %	-	-	-	-	-	-	5.5%	5.8%	6.0%	6.8%	4.1%	-	2.1%	5.9%	7.9%	7.9%
ROE %	9.5%	10.7%	9.0%	9.4%	7.3%	8.4%	7.5%	8.0%	8.0%	8.8%	5.3%	-	2.6%	7.4%	10.4%	11.2%
ROCE %	-	12.1%	9.8%	8.8%	7.6%	7.5%	6.5%	5.7%	6.1%	4.5%	4.5%	-	2.7%	5.2%	7.0%	10.1%

Shareholding Pattern

Insiders

18.93%

Institutions

67.62%

Public Float

83.40%

Top Institutional Holders

#	Holder	% Held	Shares	Value
1	Blackrock Inc.	12.13%	1.90M	$349.52M
2	Morgan Stanley Institutional Investment Advisors LLC	6.65%	1.04M	$191.58M
3	Dimensional Fund Advisors LP	6.06%	946.98K	$174.64M
4	Vanguard Portfolio Management LLC	5.05%	789.42K	$145.59M
5	Vanguard Capital Management LLC	3.52%	549.55K	$101.35M
6	First Trust Advisors LP	3.40%	530.30K	$97.80M
7	State Street Corporation	3.15%	491.57K	$90.66M
8	M Holdings Securities, Inc.	2.96%	462.41K	$85.28M
9	Renaissance Technologies, LLC	2.15%	335.52K	$61.88M
10	Geode Capital Management, LLC	2.07%	323.27K	$59.62M

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for NHC

No recent headlines available.

NHC · Healthcare